The latest price target for Evotec (NASDAQ:EVO) was reported by HC Wainwright & Co. on November 7, 2024. The analyst firm set a price target for $8.00 expecting EVO to rise to within 12 months (a possible 69.13% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Evotec (NASDAQ:EVO) was provided by HC Wainwright & Co., and Evotec reiterated their buy rating.

The last upgrade for Evotec SE happened on June 23, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Evotec SE.

The last downgrade for Evotec SE happened on October 7, 2024 when Jefferies changed their price target from $8.7 to $3.8 for Evotec SE.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evotec, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evotec was filed on November 7, 2024 so you should expect the next rating to be made available sometime around November 7, 2025.

While ratings are subjective and will change, the latest Evotec (EVO) rating was a reiterated with a price target of $8.00 to $8.00. The current price Evotec (EVO) is trading at is $4.73, which is out of the analyst’s predicted range.